• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Psychedelic Decriminalization Update

Jason Najum by Jason Najum
March 11, 2022
in Law & Politics
Reading Time: 2 mins read
A A
Psychedelic Decriminalization Update

New Georgia Bill Proposal Would Create Psychedelic Study Committee

This week in Georgia a group of bipartisan state politicians filed a resolution asking for the formation of a committee to investigate the therapeutic potential of psychedelics.

The goal of the study would be to make recommendations for reforms, and the resolution speaks of the pressing need to find new treatments for PTSD for veterans and other mental health issues like depression. 

If passed, the committee would be a mix from both parties, including high-ranking members like the chair of the Defense and Veterans Committee and members of the Department of Veterans Affair. This mix of officials, in a conservative state like Georgia, shows how quickly stigmas are changing. 

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Republican Lawmaker Files Bill to Decrim Psychedelics 

Earlier this week a Republican lawmaker in Missouri proposed a bill to legalize psychedelics. Happening again in a pretty conservative state, the legislation would make it legal to use psychedelics for therapeutic use at designated care facilities. 

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

This is a bigger move than other recent proposals, going as far as decriminalizing possession in low-levels and providing legal protections to doctors who recommend “natural medicine”.  

“no state agency or regulatory board shall revoke, fail to renew, or take any other action against a physician’s license…based solely on the physician’s recommendation to an eligible patient regarding treatment with natural medicine.” Very cool that they’re starting to use this language. 

Lasix Available Today

 

More Decrim News…

  • Washington State lawmakers approved a budget bill that would direct $200,000 in funding to study the legalization of psilocybin services. See this link from Marijuana Movement for more details. 
  • At the end of Feb, Utah lawmakers passed a bill to study the therapeutic potential of psychedelic drugs and possible decrim recommendations. The bill was bipartisan and is awaiting the governor’s signature.
  • In Oklahoma, the House approved a bill to decrimi possession of small amounts of psilocybin and promote research into psychedelics, sending it to the Senate for a vote. Another important move in a very red state. 
  • In the Oregon Senate, a committee advanced a bill that would require a focus on equity be built into the state’s psilocybin program.

Psilocybin Health Equity, SB1580 has passed out of the Senate Committee on Human Services, Mental Health and Recovery by a vote of 3 yes – 2 excused!

Track this bill through our live bill tracker: https://t.co/FZKLjnmlLD

*Bills are being added and updated in real time. pic.twitter.com/z5Yb64Gd1z

— Akasha Lawrence Spence (@teamakasha) February 18, 2022

 

 

Want to see more decrim updates? Click here

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Decriminalization
Jason Najum

Jason Najum

Jason Najum's work has appeared in many industry-leading publications, covering topics ranging from cleantech start-ups to travel and culture. He's currently Microdose's Managing Editor and Senior Writer. Write him at jason@microdose.buzz and see his work at www.jasonnajum.com

Next Post
Sex & Psychedelics: Altering Our States of Consciousness

Sex & Psychedelics: Altering Our States of Consciousness

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.